Oxaliplatin (NSC-266046) Plus Protracted Infusion 5-Fluorouracil And Radiation For Potentially Curable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Oxaliplatin (NSC-266046) Plus Protracted Infusion 5-Fluorouracil And Radiation For Potentially Curable Esophageal Cancer: A Phase II Trial With Molecular Correlates
RATIONALE: Drugs used in chemotherapy, such as oxaliplatin and fluorouracil, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Oxaliplatin and fluorouracil may make tumor cells more sensitive to radiation therapy and may kill more tumor cells. Giving chemotherapy and radiation therapy before surgery may shrink the tumor so that it can be removed.
PURPOSE: This phase II trial is studying how well giving oxaliplatin together with fluorouracil and radiation therapy works in treating patients who are undergoing surgery for stage II or stage III cancer of the esophagus or gastroesophageal junction.
OBJECTIVES:
Primary
Secondary
Exploratory Analyses (subject to funding availability)
OUTLINE: This is a multicenter study.
Treatment continues in the absence of unacceptable toxicity or disease progression.
Patients are followed every 3 months for 1 year and then every 6 months for 2 years.
PROJECTED ACCRUAL: A total of 45-85 patients will be accrued for this study within 17-21 months.
DISEASE CHARACTERISTICS:
Histologically confirmed primary adenocarcinoma of the thoracic esophagus or gastroesophageal junction
Clinical stage II or III disease by CT scan or MRI
Measurable or non-measurable disease by x-ray, scanning, or physical examination
No celiac axis nodes ≥ 1.5 cm
PATIENT CHARACTERISTICS:
Age
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
Cardiovascular
Pulmonary
Other
PRIOR CONCURRENT THERAPY:
Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
Los Angeles, California 90089-9181, United States
Palm Springs, California 92262, United States
Savannah, Georgia 31403-3089, United States
Maywood, Illinois 60153, United States
Beech Grove, Indiana 46107, United States
Kansas City, Kansas 66160-7357, United States
Wichita, Kansas 67214, United States
Lexington, Kentucky 40536-0093, United States
Gape Girardeau, Missouri 63701, United States
Billings, Montana 59101, United States
Missoula, Montana 59807, United States
Middletown, New York 10940-4199, United States
Greensboro, North Carolina 27403-1198, United States
Spartanburg, South Carolina 29303, United States
Kingsport, Tennessee 37662, United States
Murray, Utah 84157, United States
Seattle, Washington 98122-4307, United States
Seattle, Washington 98195-6043, United States